These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23947917)

  • 1. Contribution of electrostatics to the binding of pancreatic-type ribonucleases to membranes.
    Sundlass NK; Eller CH; Cui Q; Raines RT
    Biochemistry; 2013 Sep; 52(37):6304-12. PubMed ID: 23947917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity engineered on human pancreatic ribonuclease and onconase.
    Torrent G; Ribó M; Benito A; Vilanova M
    Mol Pharm; 2009; 6(2):531-42. PubMed ID: 19718804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.
    Wu Y; Mikulski SM; Ardelt W; Rybak SM; Youle RJ
    J Biol Chem; 1993 May; 268(14):10686-93. PubMed ID: 8486718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissimilarity in the reductive unfolding pathways of two ribonuclease homologues.
    Narayan M; Xu G; Ripoll DR; Zhai H; Breuker K; Wanjalla C; Leung HJ; Navon A; Welker E; McLafferty FW; Scheraga HA
    J Mol Biol; 2004 May; 338(4):795-809. PubMed ID: 15099746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A localized specific interaction alters the unfolding pathways of structural homologues.
    Xu G; Narayan M; Kurinov I; Ripoll DR; Welker E; Khalili M; Ealick SE; Scheraga HA
    J Am Chem Soc; 2006 Feb; 128(4):1204-13. PubMed ID: 16433537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide substrate binding characterization in human pancreatic-type ribonucleases.
    Bafna K; Narayanan C; Chennubhotla SC; Doucet N; Agarwal PK
    PLoS One; 2019; 14(8):e0220037. PubMed ID: 31393891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of folding kinetics with the number and isomerization states of prolines in three homologous proteins of the RNase family.
    Pradeep L; Shin HC; Scheraga HA
    FEBS Lett; 2006 Sep; 580(21):5029-32. PubMed ID: 16949585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissimilarity in the oxidative folding of onconase and ribonuclease A, two structural homologues.
    Gahl RF; Narayan M; Xu G; Scheraga HA
    Protein Eng Des Sel; 2008 Apr; 21(4):223-31. PubMed ID: 18245105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational stability is a determinant of ribonuclease A cytotoxicity.
    Klink TA; Raines RT
    J Biol Chem; 2000 Jun; 275(23):17463-7. PubMed ID: 10747991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the structural and functional properties of RNase A and BS-RNase: a stepwise mutagenesis approach.
    Ercole C; Colamarino RA; Pizzo E; Fogolari F; Spadaccini R; Picone D
    Biopolymers; 2009 Dec; 91(12):1009-17. PubMed ID: 19263489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
    Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
    J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and analysis of nonpolar regions in onconase.
    Kolbanovskaya EY; Terwisscha van Scheltinga AC; Mukhortov VG; Ardelt W; Beintema JJ; Karpeisky MY
    Cell Mol Life Sci; 2000 Aug; 57(8-9):1306-16. PubMed ID: 11028920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the action of bovine ribonuclease A and pancreatic-type ribonucleases on double-stranded RNA.
    Libonati M; Sorrentino S
    Mol Cell Biochem; 1992 Nov; 117(2):139-51. PubMed ID: 1488047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of active-site residues to the function of onconase, a ribonuclease with antitumoral activity.
    Lee JE; Raines RT
    Biochemistry; 2003 Oct; 42(39):11443-50. PubMed ID: 14516195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endowing human pancreatic ribonuclease with toxicity for cancer cells.
    Leland PA; Staniszewski KE; Kim BM; Raines RT
    J Biol Chem; 2001 Nov; 276(46):43095-102. PubMed ID: 11555655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative folding pathway of onconase, a ribonuclease homologue: insight into oxidative folding mechanisms from a study of two homologues.
    Gahl RF; Scheraga HA
    Biochemistry; 2009 Mar; 48(12):2740-51. PubMed ID: 19309163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It takes two to flirt with a dimeric RNase.
    D'Alessio G
    Biopolymers; 2009 Dec; 91(12):989-94. PubMed ID: 19156888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway.
    Haigis MC; Raines RT
    J Cell Sci; 2003 Jan; 116(Pt 2):313-24. PubMed ID: 12482917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.